Direct-Acting Antiviral Use for Genotype 1b Hepatitis C Patients with Associated Hematological Disorders from Romania

Direct-Acting Antiviral Use for Genotype 1b Hepatitis C Patients with Associated Hematological Disorders from Romania

<i>Background and objectives</i>: this study assessed variations in the blood parameters of patients with hematological disorders infected with HCV throughout a 12-week interferon-free treatment regimen. <i>Materials and methods:</i> We followed a total of 344 patients suffer...

Full description

Bibliographic Details
Main Authors: Iosif Marincu, Felix Bratosin, Manuela Curescu, Oana Suciu, Mirela Turaiche, Bianca Cerbu, Iulia Vidican
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Medicina
Subjects:
hepatitis C
direct-acting antiviral therapy
hematological disorders
Viekirax
Exviera
Harvoni
Online Access:https://www.mdpi.com/1648-9144/57/9/986

Internet

https://www.mdpi.com/1648-9144/57/9/986

Similar Items